Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
复制标题
DOI：
10.1016/j.clinthera.2007.08.005
复制
发表时间：
2007-08
影响因子：
3.2
通讯作者：
A. O'Farrell;A. V. van Vliet;Khalid Abou Farha;J. Cherrington;David Campbell;Xinqiang Li;D. Hanway;Jianke Li;H. Guler
中科院分区：
文献类型：
--
作者：
A. O'Farrell;A. V. van Vliet;Khalid Abou Farha;J. Cherrington;David Campbell;Xinqiang Li;D. Hanway;Jianke Li;H. Guler
